Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare
Free Samples
Cancer

PUBLISHER: Global Industry Analysts, Inc. | PRODUCT CODE: 1351472

Cover Image

PUBLISHER: Global Industry Analysts, Inc. | PRODUCT CODE: 1351472

Oncology Nutrition

PUBLISHED:
PAGES: 352 Pages
DELIVERY TIME: 1-2 business days
REQUEST FREE SAMPLE
REQUEST CUSTOMIZATION
SELECT AN OPTION
PDF (Single User License)
USD 4950
PDF (Global License to Company and its Fully-owned Subsidiaries)
USD 14850

Add to Cart

Description

Table of Contents

What`s New?

» Special discussions on the global economic climate and market sentiment

» Coverage on global competitiveness and key competitor percentage market shares

» Market presence analysis across multiple geographies - Strong/Active/Niche/Trivial

» Online interactive peer-to-peer collaborative bespoke updates

» Access to our digital archives and MarketGlass™ research platform

» Complimentary updates for one year

» Access to curated YouTube video transcripts of market sentiments shared by CEOs, domain experts and market influencers via interviews, podcasts, press statements and event keynotes

Economic Outlook

The global economic outlook is improving, and growth recovery, albeit on the lower side, is expected for this year and the next. The United States although witnessing slowing GDP growth in response to tight monetary and financial conditions, has nevertheless overcome the recession threat. Easing of headline inflation in Euro area is helping boost real incomes and is contributing to pick-up in economic activity. China is expected to see strong increases in GDP in the coming year as the pandemic threat recedes and the government sheds its zero-COVID policy. With optimistic GDP projections, India remains on-course to emerge into a US$6 trillion economy by 2030, surpassing Japan and Germany.

The upturn, however, remains fragile and a number of interlocking challenges continue to run in parallel, such as continued uncertainty around the war in Ukraine; slower than expected decline in global headline inflation; continuation of food and fuel inflation as a persistent economic problem for most developing countries; and still high retail inflation and its impact on consumer confidence and spending. Countries and their governments are showing signs of weathering these challenges, which helps lift market sentiments. As governments continue to combat inflation to get it down to more economically conformable levels by raising interest rates, new job creation will slowdown and impact economic activity. Stricter regulatory environment and pressure to mainstream climate change into economic decisions will compound the complexity of challenges faced.

Although corporate investments can likely be held back by inflation worries and weaker demand, rise of new technologies will reverse partially this prevailing investment sentiment. Rise of generative AI; applied AI; industrializing machine learning; next-generation software development; Web3; cloud and edge computing; quantum technologies; electrification and renewables and climate technologies beyond electrification and renewables, will open up the global investment landscape. The technologies hold the potential to drive sizeable incremental growth and value to global GDP in the coming years. The short-term is expected to be a mixed bag of challenges and opportunities for both consumers and investors alike. There is always opportunity for businesses and their leaders who can chart a path forward with resilience and adaptability.

Global Oncology Nutrition Market to Reach $2.5 Billion by 2030

The global market for Oncology Nutrition estimated at US$1.2 Billion in the year 2022, is projected to reach a revised size of US$2.5 Billion by 2030, growing at a CAGR of 9.3% over the period 2022-2030. Head & Neck, one of the segments analyzed in the report, is projected to record 8.3% CAGR and reach US$609.6 Million by the end of the analysis period. Growth in the Stomach & Gastrointestinal segment is estimated at 11.5% CAGR for the next 8-year period.

The U.S. Market is Estimated at $443.3 Million, While China is Forecast to Grow at 11.3% CAGR

The Oncology Nutrition market in the U.S. is estimated at US$443.3 Million in the year 2022. China, the world`s second largest economy, is forecast to reach a projected market size of US$254.5 Million by the year 2030 trailing a CAGR of 11.3% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 8.1% and 7.7% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 9.1% CAGR.

Select Competitors (Total 31 Featured) -

  • Abbott Laboratories, Inc.
  • B. Braun Melsungen AG
  • Koninklijke DSM N.V.
  • Baxter International, Inc.
  • Fresenius Kabi AG
  • Fresenius SE & Co. KGaA
  • Aceto Corporation
  • Meiji Holdings Co., Ltd.
  • Nestle Health Science SA
  • Mead Johnson & Company, LLC.
  • Nutricia BV
  • Alniche Life Sciences Pvt., Ltd.
  • Global Health Products, Inc.
  • Pristine Organics Pvt. Ltd.
  • Hexagon Nutrition
Show more
Product Code: MCP13705

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Oncology Nutrition - Global Key Competitors Percentage Market Share in 2022 (E)
    • Impact of Covid-19 and a Looming Global Recession
    • 2020 Marked as a Year of Disruption & Transformation
    • With IMF Making an Upward Revision of Global GDP for 2021, Companies Are Bullish About an Economic Comeback Despite a Continuing Pandemic
    • A Strong Yet Exceedingly Patchy & Uncertain Recovery Shaped by New Variants Comes Into Play: World Economic Growth Projections (Real GDP, Annual % Change) for 2020 through 2022
    • COVID-19 Impact On Oncology Nutrition
    • Cancer - Food choices, Dietary habits and Cancer risk
    • Significance of Proper Nutrition for Cancer Patients
    • What to Eat in Cancer
    • Importance of Adequate Nutrition during Cancer Treatment
    • Nutrition During Cancer Treatment
    • Common Causes of Nutrition and Malnutrition in Cancer Patients
    • Cancer Treatment Side Effects that are Likely to Cause Dehydration and Malnutrition
    • Commercial Feeding Formulas
    • Factors to be Considered When Selecting a Particular Formula
    • Global Market Analysis and Prospects
    • Global Oncology Nutrition Market Witnesses Rapid Growth
    • Developed Regions Account for Major Share, Developing Regions Witness Rapid Growth
    • Competition
    • Recent Market Activity
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Global Incidence of Cancer Drives the Oncology Nutrition Market
    • Breakdown of Total Number of Cancer Cases by Region: 2020
    • Breakdown of Total Number of Cancer Cases by Type: 2020
    • Global Cancer Incidence: Number of New Cancer Cases in Million for the Years 2018, 2020, 2025, 2030, 2035 and 2040
    • Rising Number of Malnourished Cancer Patients Drive the Demand for Oncology Nutrition Market
    • Patient Diagnosis with Malnutrition
    • Post Treatment Duration and Nutrition for Advanced Cancer
    • Meeting Nutritional Needs of Cancer Patients
    • Nutrition for Breast Cancer Survivorship
    • Introduction of Nutrient-Rich Oncology Nutritional Supplements Ensure Quick Recovery for Cancer Patients
    • Ongoing Research and Development Initiatives Fuel Demand for Oncology Nutrition Products
    • Demand for Gluten and Lactose-Free Enteral Nutrition Formulas Exhibits an Upward Momentum
    • Launch of New Nutritional Products for Cancer Patients
    • Diet for Colon Cancer Surgery
    • Ageing Demographics to Drive Market Demand
    • Global Aging Population Statistics for the 65+ Age Group in Million by Geographic Region for the Years 2019, 2025, 2035 and 2050
    • Elderly Population (65+ Years) as a % of Total Population by Developed, Less Developed and Least Developed Regions: 2019 & 2030
    • Uptrend in Healthcare Spending Drives Market Demand
    • World Healthcare Expenditure (In US$ Billion) for the Years 2017-2023
    • Healthcare Costs as a % of GDP by Country for the Years 2020 & 2023
    • Enteral Nutrition Market to Remain Buoyant and Strong
    • Oncology Applications Leads EN Market
    • Shift towards Home Care Boosts Demand for Clinical Nutrition Products
    • Trend towards Home Healthcare to Propel Home Clinical Nutrition Market - Global Home Healthcare Revenues (in US$ Billion) for the Years 2016, 2018 & 2020
    • Changing Health and Social Care Factors Favor Home Enteral Feeding
    • Increasing Popularity of Intravenous Vitamin C for Cancer Treatment
    • Shift towards Enteral Nutrition Therapies - A Threat to Parenteral Nutrition Market
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Oncology Nutrition by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 2: World Historic Review for Oncology Nutrition by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 3: World 16-Year Perspective for Oncology Nutrition by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2023 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Head & Neck by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 5: World Historic Review for Head & Neck by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 6: World 16-Year Perspective for Head & Neck by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Stomach & Gastrointestinal by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 8: World Historic Review for Stomach & Gastrointestinal by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 9: World 16-Year Perspective for Stomach & Gastrointestinal by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Pancreatic by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 11: World Historic Review for Pancreatic by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 12: World 16-Year Perspective for Pancreatic by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for Breast by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 14: World Historic Review for Breast by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 15: World 16-Year Perspective for Breast by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Liver by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 17: World Historic Review for Liver by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 18: World 16-Year Perspective for Liver by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
    • TABLE 19: World Recent Past, Current & Future Analysis for Other Cancer Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 20: World Historic Review for Other Cancer Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 21: World 16-Year Perspective for Other Cancer Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
    • TABLE 22: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 23: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 24: World 16-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
    • TABLE 25: World Recent Past, Current & Future Analysis for Home Care by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 26: World Historic Review for Home Care by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 27: World 16-Year Perspective for Home Care by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
    • TABLE 28: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 29: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 30: World 16-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
    • TABLE 31: World Oncology Nutrition Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Oncology Nutrition Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2023 (E)
    • TABLE 32: USA Recent Past, Current & Future Analysis for Oncology Nutrition by Cancer Type - Head & Neck, Stomach & Gastrointestinal, Pancreatic, Breast, Liver and Other Cancer Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 33: USA Historic Review for Oncology Nutrition by Cancer Type - Head & Neck, Stomach & Gastrointestinal, Pancreatic, Breast, Liver and Other Cancer Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 34: USA 16-Year Perspective for Oncology Nutrition by Cancer Type - Percentage Breakdown of Value Sales for Head & Neck, Stomach & Gastrointestinal, Pancreatic, Breast, Liver and Other Cancer Types for the Years 2014, 2023 & 2030
    • TABLE 35: USA Recent Past, Current & Future Analysis for Oncology Nutrition by End-Use - Hospitals, Home Care and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 36: USA Historic Review for Oncology Nutrition by End-Use - Hospitals, Home Care and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 37: USA 16-Year Perspective for Oncology Nutrition by End-Use - Percentage Breakdown of Value Sales for Hospitals, Home Care and Other End-Uses for the Years 2014, 2023 & 2030
  • CANADA
    • TABLE 38: Canada Recent Past, Current & Future Analysis for Oncology Nutrition by Cancer Type - Head & Neck, Stomach & Gastrointestinal, Pancreatic, Breast, Liver and Other Cancer Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 39: Canada Historic Review for Oncology Nutrition by Cancer Type - Head & Neck, Stomach & Gastrointestinal, Pancreatic, Breast, Liver and Other Cancer Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 40: Canada 16-Year Perspective for Oncology Nutrition by Cancer Type - Percentage Breakdown of Value Sales for Head & Neck, Stomach & Gastrointestinal, Pancreatic, Breast, Liver and Other Cancer Types for the Years 2014, 2023 & 2030
    • TABLE 41: Canada Recent Past, Current & Future Analysis for Oncology Nutrition by End-Use - Hospitals, Home Care and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 42: Canada Historic Review for Oncology Nutrition by End-Use - Hospitals, Home Care and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 43: Canada 16-Year Perspective for Oncology Nutrition by End-Use - Percentage Breakdown of Value Sales for Hospitals, Home Care and Other End-Uses for the Years 2014, 2023 & 2030
  • JAPAN
    • Oncology Nutrition Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2023 (E)
    • TABLE 44: Japan Recent Past, Current & Future Analysis for Oncology Nutrition by Cancer Type - Head & Neck, Stomach & Gastrointestinal, Pancreatic, Breast, Liver and Other Cancer Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 45: Japan Historic Review for Oncology Nutrition by Cancer Type - Head & Neck, Stomach & Gastrointestinal, Pancreatic, Breast, Liver and Other Cancer Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 46: Japan 16-Year Perspective for Oncology Nutrition by Cancer Type - Percentage Breakdown of Value Sales for Head & Neck, Stomach & Gastrointestinal, Pancreatic, Breast, Liver and Other Cancer Types for the Years 2014, 2023 & 2030
    • TABLE 47: Japan Recent Past, Current & Future Analysis for Oncology Nutrition by End-Use - Hospitals, Home Care and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 48: Japan Historic Review for Oncology Nutrition by End-Use - Hospitals, Home Care and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 49: Japan 16-Year Perspective for Oncology Nutrition by End-Use - Percentage Breakdown of Value Sales for Hospitals, Home Care and Other End-Uses for the Years 2014, 2023 & 2030
  • CHINA
    • Oncology Nutrition Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2023 (E)
    • TABLE 50: China Recent Past, Current & Future Analysis for Oncology Nutrition by Cancer Type - Head & Neck, Stomach & Gastrointestinal, Pancreatic, Breast, Liver and Other Cancer Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 51: China Historic Review for Oncology Nutrition by Cancer Type - Head & Neck, Stomach & Gastrointestinal, Pancreatic, Breast, Liver and Other Cancer Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 52: China 16-Year Perspective for Oncology Nutrition by Cancer Type - Percentage Breakdown of Value Sales for Head & Neck, Stomach & Gastrointestinal, Pancreatic, Breast, Liver and Other Cancer Types for the Years 2014, 2023 & 2030
    • TABLE 53: China Recent Past, Current & Future Analysis for Oncology Nutrition by End-Use - Hospitals, Home Care and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 54: China Historic Review for Oncology Nutrition by End-Use - Hospitals, Home Care and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 55: China 16-Year Perspective for Oncology Nutrition by End-Use - Percentage Breakdown of Value Sales for Hospitals, Home Care and Other End-Uses for the Years 2014, 2023 & 2030
  • EUROPE
    • Oncology Nutrition Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2023 (E)
    • TABLE 56: Europe Recent Past, Current & Future Analysis for Oncology Nutrition by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 57: Europe Historic Review for Oncology Nutrition by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 58: Europe 16-Year Perspective for Oncology Nutrition by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2023 & 2030
    • TABLE 59: Europe Recent Past, Current & Future Analysis for Oncology Nutrition by Cancer Type - Head & Neck, Stomach & Gastrointestinal, Pancreatic, Breast, Liver and Other Cancer Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 60: Europe Historic Review for Oncology Nutrition by Cancer Type - Head & Neck, Stomach & Gastrointestinal, Pancreatic, Breast, Liver and Other Cancer Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 61: Europe 16-Year Perspective for Oncology Nutrition by Cancer Type - Percentage Breakdown of Value Sales for Head & Neck, Stomach & Gastrointestinal, Pancreatic, Breast, Liver and Other Cancer Types for the Years 2014, 2023 & 2030
    • TABLE 62: Europe Recent Past, Current & Future Analysis for Oncology Nutrition by End-Use - Hospitals, Home Care and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 63: Europe Historic Review for Oncology Nutrition by End-Use - Hospitals, Home Care and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 64: Europe 16-Year Perspective for Oncology Nutrition by End-Use - Percentage Breakdown of Value Sales for Hospitals, Home Care and Other End-Uses for the Years 2014, 2023 & 2030
  • FRANCE
    • Oncology Nutrition Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2023 (E)
    • TABLE 65: France Recent Past, Current & Future Analysis for Oncology Nutrition by Cancer Type - Head & Neck, Stomach & Gastrointestinal, Pancreatic, Breast, Liver and Other Cancer Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 66: France Historic Review for Oncology Nutrition by Cancer Type - Head & Neck, Stomach & Gastrointestinal, Pancreatic, Breast, Liver and Other Cancer Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 67: France 16-Year Perspective for Oncology Nutrition by Cancer Type - Percentage Breakdown of Value Sales for Head & Neck, Stomach & Gastrointestinal, Pancreatic, Breast, Liver and Other Cancer Types for the Years 2014, 2023 & 2030
    • TABLE 68: France Recent Past, Current & Future Analysis for Oncology Nutrition by End-Use - Hospitals, Home Care and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 69: France Historic Review for Oncology Nutrition by End-Use - Hospitals, Home Care and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 70: France 16-Year Perspective for Oncology Nutrition by End-Use - Percentage Breakdown of Value Sales for Hospitals, Home Care and Other End-Uses for the Years 2014, 2023 & 2030
  • GERMANY
    • Oncology Nutrition Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2023 (E)
    • TABLE 71: Germany Recent Past, Current & Future Analysis for Oncology Nutrition by Cancer Type - Head & Neck, Stomach & Gastrointestinal, Pancreatic, Breast, Liver and Other Cancer Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 72: Germany Historic Review for Oncology Nutrition by Cancer Type - Head & Neck, Stomach & Gastrointestinal, Pancreatic, Breast, Liver and Other Cancer Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 73: Germany 16-Year Perspective for Oncology Nutrition by Cancer Type - Percentage Breakdown of Value Sales for Head & Neck, Stomach & Gastrointestinal, Pancreatic, Breast, Liver and Other Cancer Types for the Years 2014, 2023 & 2030
    • TABLE 74: Germany Recent Past, Current & Future Analysis for Oncology Nutrition by End-Use - Hospitals, Home Care and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 75: Germany Historic Review for Oncology Nutrition by End-Use - Hospitals, Home Care and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 76: Germany 16-Year Perspective for Oncology Nutrition by End-Use - Percentage Breakdown of Value Sales for Hospitals, Home Care and Other End-Uses for the Years 2014, 2023 & 2030
  • ITALY
    • TABLE 77: Italy Recent Past, Current & Future Analysis for Oncology Nutrition by Cancer Type - Head & Neck, Stomach & Gastrointestinal, Pancreatic, Breast, Liver and Other Cancer Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 78: Italy Historic Review for Oncology Nutrition by Cancer Type - Head & Neck, Stomach & Gastrointestinal, Pancreatic, Breast, Liver and Other Cancer Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 79: Italy 16-Year Perspective for Oncology Nutrition by Cancer Type - Percentage Breakdown of Value Sales for Head & Neck, Stomach & Gastrointestinal, Pancreatic, Breast, Liver and Other Cancer Types for the Years 2014, 2023 & 2030
    • TABLE 80: Italy Recent Past, Current & Future Analysis for Oncology Nutrition by End-Use - Hospitals, Home Care and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 81: Italy Historic Review for Oncology Nutrition by End-Use - Hospitals, Home Care and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 82: Italy 16-Year Perspective for Oncology Nutrition by End-Use - Percentage Breakdown of Value Sales for Hospitals, Home Care and Other End-Uses for the Years 2014, 2023 & 2030
  • UNITED KINGDOM
    • Oncology Nutrition Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2023 (E)
    • TABLE 83: UK Recent Past, Current & Future Analysis for Oncology Nutrition by Cancer Type - Head & Neck, Stomach & Gastrointestinal, Pancreatic, Breast, Liver and Other Cancer Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 84: UK Historic Review for Oncology Nutrition by Cancer Type - Head & Neck, Stomach & Gastrointestinal, Pancreatic, Breast, Liver and Other Cancer Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 85: UK 16-Year Perspective for Oncology Nutrition by Cancer Type - Percentage Breakdown of Value Sales for Head & Neck, Stomach & Gastrointestinal, Pancreatic, Breast, Liver and Other Cancer Types for the Years 2014, 2023 & 2030
    • TABLE 86: UK Recent Past, Current & Future Analysis for Oncology Nutrition by End-Use - Hospitals, Home Care and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 87: UK Historic Review for Oncology Nutrition by End-Use - Hospitals, Home Care and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 88: UK 16-Year Perspective for Oncology Nutrition by End-Use - Percentage Breakdown of Value Sales for Hospitals, Home Care and Other End-Uses for the Years 2014, 2023 & 2030
  • SPAIN
    • TABLE 89: Spain Recent Past, Current & Future Analysis for Oncology Nutrition by Cancer Type - Head & Neck, Stomach & Gastrointestinal, Pancreatic, Breast, Liver and Other Cancer Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 90: Spain Historic Review for Oncology Nutrition by Cancer Type - Head & Neck, Stomach & Gastrointestinal, Pancreatic, Breast, Liver and Other Cancer Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 91: Spain 16-Year Perspective for Oncology Nutrition by Cancer Type - Percentage Breakdown of Value Sales for Head & Neck, Stomach & Gastrointestinal, Pancreatic, Breast, Liver and Other Cancer Types for the Years 2014, 2023 & 2030
    • TABLE 92: Spain Recent Past, Current & Future Analysis for Oncology Nutrition by End-Use - Hospitals, Home Care and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 93: Spain Historic Review for Oncology Nutrition by End-Use - Hospitals, Home Care and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 94: Spain 16-Year Perspective for Oncology Nutrition by End-Use - Percentage Breakdown of Value Sales for Hospitals, Home Care and Other End-Uses for the Years 2014, 2023 & 2030
  • RUSSIA
    • TABLE 95: Russia Recent Past, Current & Future Analysis for Oncology Nutrition by Cancer Type - Head & Neck, Stomach & Gastrointestinal, Pancreatic, Breast, Liver and Other Cancer Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 96: Russia Historic Review for Oncology Nutrition by Cancer Type - Head & Neck, Stomach & Gastrointestinal, Pancreatic, Breast, Liver and Other Cancer Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 97: Russia 16-Year Perspective for Oncology Nutrition by Cancer Type - Percentage Breakdown of Value Sales for Head & Neck, Stomach & Gastrointestinal, Pancreatic, Breast, Liver and Other Cancer Types for the Years 2014, 2023 & 2030
    • TABLE 98: Russia Recent Past, Current & Future Analysis for Oncology Nutrition by End-Use - Hospitals, Home Care and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 99: Russia Historic Review for Oncology Nutrition by End-Use - Hospitals, Home Care and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 100: Russia 16-Year Perspective for Oncology Nutrition by End-Use - Percentage Breakdown of Value Sales for Hospitals, Home Care and Other End-Uses for the Years 2014, 2023 & 2030
  • REST OF EUROPE
    • TABLE 101: Rest of Europe Recent Past, Current & Future Analysis for Oncology Nutrition by Cancer Type - Head & Neck, Stomach & Gastrointestinal, Pancreatic, Breast, Liver and Other Cancer Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 102: Rest of Europe Historic Review for Oncology Nutrition by Cancer Type - Head & Neck, Stomach & Gastrointestinal, Pancreatic, Breast, Liver and Other Cancer Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 103: Rest of Europe 16-Year Perspective for Oncology Nutrition by Cancer Type - Percentage Breakdown of Value Sales for Head & Neck, Stomach & Gastrointestinal, Pancreatic, Breast, Liver and Other Cancer Types for the Years 2014, 2023 & 2030
    • TABLE 104: Rest of Europe Recent Past, Current & Future Analysis for Oncology Nutrition by End-Use - Hospitals, Home Care and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 105: Rest of Europe Historic Review for Oncology Nutrition by End-Use - Hospitals, Home Care and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 106: Rest of Europe 16-Year Perspective for Oncology Nutrition by End-Use - Percentage Breakdown of Value Sales for Hospitals, Home Care and Other End-Uses for the Years 2014, 2023 & 2030
  • ASIA-PACIFIC
    • Oncology Nutrition Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2023 (E)
    • TABLE 107: Asia-Pacific Recent Past, Current & Future Analysis for Oncology Nutrition by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 108: Asia-Pacific Historic Review for Oncology Nutrition by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 109: Asia-Pacific 16-Year Perspective for Oncology Nutrition by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2023 & 2030
    • TABLE 110: Asia-Pacific Recent Past, Current & Future Analysis for Oncology Nutrition by Cancer Type - Head & Neck, Stomach & Gastrointestinal, Pancreatic, Breast, Liver and Other Cancer Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 111: Asia-Pacific Historic Review for Oncology Nutrition by Cancer Type - Head & Neck, Stomach & Gastrointestinal, Pancreatic, Breast, Liver and Other Cancer Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 112: Asia-Pacific 16-Year Perspective for Oncology Nutrition by Cancer Type - Percentage Breakdown of Value Sales for Head & Neck, Stomach & Gastrointestinal, Pancreatic, Breast, Liver and Other Cancer Types for the Years 2014, 2023 & 2030
    • TABLE 113: Asia-Pacific Recent Past, Current & Future Analysis for Oncology Nutrition by End-Use - Hospitals, Home Care and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 114: Asia-Pacific Historic Review for Oncology Nutrition by End-Use - Hospitals, Home Care and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 115: Asia-Pacific 16-Year Perspective for Oncology Nutrition by End-Use - Percentage Breakdown of Value Sales for Hospitals, Home Care and Other End-Uses for the Years 2014, 2023 & 2030
  • AUSTRALIA
    • Oncology Nutrition Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2023 (E)
    • TABLE 116: Australia Recent Past, Current & Future Analysis for Oncology Nutrition by Cancer Type - Head & Neck, Stomach & Gastrointestinal, Pancreatic, Breast, Liver and Other Cancer Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 117: Australia Historic Review for Oncology Nutrition by Cancer Type - Head & Neck, Stomach & Gastrointestinal, Pancreatic, Breast, Liver and Other Cancer Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 118: Australia 16-Year Perspective for Oncology Nutrition by Cancer Type - Percentage Breakdown of Value Sales for Head & Neck, Stomach & Gastrointestinal, Pancreatic, Breast, Liver and Other Cancer Types for the Years 2014, 2023 & 2030
    • TABLE 119: Australia Recent Past, Current & Future Analysis for Oncology Nutrition by End-Use - Hospitals, Home Care and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 120: Australia Historic Review for Oncology Nutrition by End-Use - Hospitals, Home Care and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 121: Australia 16-Year Perspective for Oncology Nutrition by End-Use - Percentage Breakdown of Value Sales for Hospitals, Home Care and Other End-Uses for the Years 2014, 2023 & 2030
  • INDIA
    • Oncology Nutrition Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2023 (E)
    • TABLE 122: India Recent Past, Current & Future Analysis for Oncology Nutrition by Cancer Type - Head & Neck, Stomach & Gastrointestinal, Pancreatic, Breast, Liver and Other Cancer Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 123: India Historic Review for Oncology Nutrition by Cancer Type - Head & Neck, Stomach & Gastrointestinal, Pancreatic, Breast, Liver and Other Cancer Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 124: India 16-Year Perspective for Oncology Nutrition by Cancer Type - Percentage Breakdown of Value Sales for Head & Neck, Stomach & Gastrointestinal, Pancreatic, Breast, Liver and Other Cancer Types for the Years 2014, 2023 & 2030
    • TABLE 125: India Recent Past, Current & Future Analysis for Oncology Nutrition by End-Use - Hospitals, Home Care and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 126: India Historic Review for Oncology Nutrition by End-Use - Hospitals, Home Care and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 127: India 16-Year Perspective for Oncology Nutrition by End-Use - Percentage Breakdown of Value Sales for Hospitals, Home Care and Other End-Uses for the Years 2014, 2023 & 2030
  • SOUTH KOREA
    • TABLE 128: South Korea Recent Past, Current & Future Analysis for Oncology Nutrition by Cancer Type - Head & Neck, Stomach & Gastrointestinal, Pancreatic, Breast, Liver and Other Cancer Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 129: South Korea Historic Review for Oncology Nutrition by Cancer Type - Head & Neck, Stomach & Gastrointestinal, Pancreatic, Breast, Liver and Other Cancer Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 130: South Korea 16-Year Perspective for Oncology Nutrition by Cancer Type - Percentage Breakdown of Value Sales for Head & Neck, Stomach & Gastrointestinal, Pancreatic, Breast, Liver and Other Cancer Types for the Years 2014, 2023 & 2030
    • TABLE 131: South Korea Recent Past, Current & Future Analysis for Oncology Nutrition by End-Use - Hospitals, Home Care and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 132: South Korea Historic Review for Oncology Nutrition by End-Use - Hospitals, Home Care and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 133: South Korea 16-Year Perspective for Oncology Nutrition by End-Use - Percentage Breakdown of Value Sales for Hospitals, Home Care and Other End-Uses for the Years 2014, 2023 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 134: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Oncology Nutrition by Cancer Type - Head & Neck, Stomach & Gastrointestinal, Pancreatic, Breast, Liver and Other Cancer Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 135: Rest of Asia-Pacific Historic Review for Oncology Nutrition by Cancer Type - Head & Neck, Stomach & Gastrointestinal, Pancreatic, Breast, Liver and Other Cancer Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 136: Rest of Asia-Pacific 16-Year Perspective for Oncology Nutrition by Cancer Type - Percentage Breakdown of Value Sales for Head & Neck, Stomach & Gastrointestinal, Pancreatic, Breast, Liver and Other Cancer Types for the Years 2014, 2023 & 2030
    • TABLE 137: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Oncology Nutrition by End-Use - Hospitals, Home Care and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 138: Rest of Asia-Pacific Historic Review for Oncology Nutrition by End-Use - Hospitals, Home Care and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 139: Rest of Asia-Pacific 16-Year Perspective for Oncology Nutrition by End-Use - Percentage Breakdown of Value Sales for Hospitals, Home Care and Other End-Uses for the Years 2014, 2023 & 2030
  • LATIN AMERICA
    • Oncology Nutrition Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2023 (E)
    • TABLE 140: Latin America Recent Past, Current & Future Analysis for Oncology Nutrition by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 141: Latin America Historic Review for Oncology Nutrition by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 142: Latin America 16-Year Perspective for Oncology Nutrition by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2023 & 2030
    • TABLE 143: Latin America Recent Past, Current & Future Analysis for Oncology Nutrition by Cancer Type - Head & Neck, Stomach & Gastrointestinal, Pancreatic, Breast, Liver and Other Cancer Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 144: Latin America Historic Review for Oncology Nutrition by Cancer Type - Head & Neck, Stomach & Gastrointestinal, Pancreatic, Breast, Liver and Other Cancer Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 145: Latin America 16-Year Perspective for Oncology Nutrition by Cancer Type - Percentage Breakdown of Value Sales for Head & Neck, Stomach & Gastrointestinal, Pancreatic, Breast, Liver and Other Cancer Types for the Years 2014, 2023 & 2030
    • TABLE 146: Latin America Recent Past, Current & Future Analysis for Oncology Nutrition by End-Use - Hospitals, Home Care and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 147: Latin America Historic Review for Oncology Nutrition by End-Use - Hospitals, Home Care and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 148: Latin America 16-Year Perspective for Oncology Nutrition by End-Use - Percentage Breakdown of Value Sales for Hospitals, Home Care and Other End-Uses for the Years 2014, 2023 & 2030
  • ARGENTINA
    • TABLE 149: Argentina Recent Past, Current & Future Analysis for Oncology Nutrition by Cancer Type - Head & Neck, Stomach & Gastrointestinal, Pancreatic, Breast, Liver and Other Cancer Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 150: Argentina Historic Review for Oncology Nutrition by Cancer Type - Head & Neck, Stomach & Gastrointestinal, Pancreatic, Breast, Liver and Other Cancer Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 151: Argentina 16-Year Perspective for Oncology Nutrition by Cancer Type - Percentage Breakdown of Value Sales for Head & Neck, Stomach & Gastrointestinal, Pancreatic, Breast, Liver and Other Cancer Types for the Years 2014, 2023 & 2030
    • TABLE 152: Argentina Recent Past, Current & Future Analysis for Oncology Nutrition by End-Use - Hospitals, Home Care and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 153: Argentina Historic Review for Oncology Nutrition by End-Use - Hospitals, Home Care and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 154: Argentina 16-Year Perspective for Oncology Nutrition by End-Use - Percentage Breakdown of Value Sales for Hospitals, Home Care and Other End-Uses for the Years 2014, 2023 & 2030
  • BRAZIL
    • TABLE 155: Brazil Recent Past, Current & Future Analysis for Oncology Nutrition by Cancer Type - Head & Neck, Stomach & Gastrointestinal, Pancreatic, Breast, Liver and Other Cancer Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 156: Brazil Historic Review for Oncology Nutrition by Cancer Type - Head & Neck, Stomach & Gastrointestinal, Pancreatic, Breast, Liver and Other Cancer Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 157: Brazil 16-Year Perspective for Oncology Nutrition by Cancer Type - Percentage Breakdown of Value Sales for Head & Neck, Stomach & Gastrointestinal, Pancreatic, Breast, Liver and Other Cancer Types for the Years 2014, 2023 & 2030
    • TABLE 158: Brazil Recent Past, Current & Future Analysis for Oncology Nutrition by End-Use - Hospitals, Home Care and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 159: Brazil Historic Review for Oncology Nutrition by End-Use - Hospitals, Home Care and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 160: Brazil 16-Year Perspective for Oncology Nutrition by End-Use - Percentage Breakdown of Value Sales for Hospitals, Home Care and Other End-Uses for the Years 2014, 2023 & 2030
  • MEXICO
    • TABLE 161: Mexico Recent Past, Current & Future Analysis for Oncology Nutrition by Cancer Type - Head & Neck, Stomach & Gastrointestinal, Pancreatic, Breast, Liver and Other Cancer Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 162: Mexico Historic Review for Oncology Nutrition by Cancer Type - Head & Neck, Stomach & Gastrointestinal, Pancreatic, Breast, Liver and Other Cancer Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 163: Mexico 16-Year Perspective for Oncology Nutrition by Cancer Type - Percentage Breakdown of Value Sales for Head & Neck, Stomach & Gastrointestinal, Pancreatic, Breast, Liver and Other Cancer Types for the Years 2014, 2023 & 2030
    • TABLE 164: Mexico Recent Past, Current & Future Analysis for Oncology Nutrition by End-Use - Hospitals, Home Care and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 165: Mexico Historic Review for Oncology Nutrition by End-Use - Hospitals, Home Care and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 166: Mexico 16-Year Perspective for Oncology Nutrition by End-Use - Percentage Breakdown of Value Sales for Hospitals, Home Care and Other End-Uses for the Years 2014, 2023 & 2030
  • REST OF LATIN AMERICA
    • TABLE 167: Rest of Latin America Recent Past, Current & Future Analysis for Oncology Nutrition by Cancer Type - Head & Neck, Stomach & Gastrointestinal, Pancreatic, Breast, Liver and Other Cancer Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 168: Rest of Latin America Historic Review for Oncology Nutrition by Cancer Type - Head & Neck, Stomach & Gastrointestinal, Pancreatic, Breast, Liver and Other Cancer Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 169: Rest of Latin America 16-Year Perspective for Oncology Nutrition by Cancer Type - Percentage Breakdown of Value Sales for Head & Neck, Stomach & Gastrointestinal, Pancreatic, Breast, Liver and Other Cancer Types for the Years 2014, 2023 & 2030
    • TABLE 170: Rest of Latin America Recent Past, Current & Future Analysis for Oncology Nutrition by End-Use - Hospitals, Home Care and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 171: Rest of Latin America Historic Review for Oncology Nutrition by End-Use - Hospitals, Home Care and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 172: Rest of Latin America 16-Year Perspective for Oncology Nutrition by End-Use - Percentage Breakdown of Value Sales for Hospitals, Home Care and Other End-Uses for the Years 2014, 2023 & 2030
  • MIDDLE EAST
    • Oncology Nutrition Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2023 (E)
    • TABLE 173: Middle East Recent Past, Current & Future Analysis for Oncology Nutrition by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 174: Middle East Historic Review for Oncology Nutrition by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 175: Middle East 16-Year Perspective for Oncology Nutrition by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2023 & 2030
    • TABLE 176: Middle East Recent Past, Current & Future Analysis for Oncology Nutrition by Cancer Type - Head & Neck, Stomach & Gastrointestinal, Pancreatic, Breast, Liver and Other Cancer Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 177: Middle East Historic Review for Oncology Nutrition by Cancer Type - Head & Neck, Stomach & Gastrointestinal, Pancreatic, Breast, Liver and Other Cancer Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 178: Middle East 16-Year Perspective for Oncology Nutrition by Cancer Type - Percentage Breakdown of Value Sales for Head & Neck, Stomach & Gastrointestinal, Pancreatic, Breast, Liver and Other Cancer Types for the Years 2014, 2023 & 2030
    • TABLE 179: Middle East Recent Past, Current & Future Analysis for Oncology Nutrition by End-Use - Hospitals, Home Care and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 180: Middle East Historic Review for Oncology Nutrition by End-Use - Hospitals, Home Care and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 181: Middle East 16-Year Perspective for Oncology Nutrition by End-Use - Percentage Breakdown of Value Sales for Hospitals, Home Care and Other End-Uses for the Years 2014, 2023 & 2030
  • IRAN
    • TABLE 182: Iran Recent Past, Current & Future Analysis for Oncology Nutrition by Cancer Type - Head & Neck, Stomach & Gastrointestinal, Pancreatic, Breast, Liver and Other Cancer Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 183: Iran Historic Review for Oncology Nutrition by Cancer Type - Head & Neck, Stomach & Gastrointestinal, Pancreatic, Breast, Liver and Other Cancer Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 184: Iran 16-Year Perspective for Oncology Nutrition by Cancer Type - Percentage Breakdown of Value Sales for Head & Neck, Stomach & Gastrointestinal, Pancreatic, Breast, Liver and Other Cancer Types for the Years 2014, 2023 & 2030
    • TABLE 185: Iran Recent Past, Current & Future Analysis for Oncology Nutrition by End-Use - Hospitals, Home Care and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 186: Iran Historic Review for Oncology Nutrition by End-Use - Hospitals, Home Care and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 187: Iran 16-Year Perspective for Oncology Nutrition by End-Use - Percentage Breakdown of Value Sales for Hospitals, Home Care and Other End-Uses for the Years 2014, 2023 & 2030
  • ISRAEL
    • TABLE 188: Israel Recent Past, Current & Future Analysis for Oncology Nutrition by Cancer Type - Head & Neck, Stomach & Gastrointestinal, Pancreatic, Breast, Liver and Other Cancer Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 189: Israel Historic Review for Oncology Nutrition by Cancer Type - Head & Neck, Stomach & Gastrointestinal, Pancreatic, Breast, Liver and Other Cancer Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 190: Israel 16-Year Perspective for Oncology Nutrition by Cancer Type - Percentage Breakdown of Value Sales for Head & Neck, Stomach & Gastrointestinal, Pancreatic, Breast, Liver and Other Cancer Types for the Years 2014, 2023 & 2030
    • TABLE 191: Israel Recent Past, Current & Future Analysis for Oncology Nutrition by End-Use - Hospitals, Home Care and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 192: Israel Historic Review for Oncology Nutrition by End-Use - Hospitals, Home Care and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 193: Israel 16-Year Perspective for Oncology Nutrition by End-Use - Percentage Breakdown of Value Sales for Hospitals, Home Care and Other End-Uses for the Years 2014, 2023 & 2030
  • SAUDI ARABIA
    • TABLE 194: Saudi Arabia Recent Past, Current & Future Analysis for Oncology Nutrition by Cancer Type - Head & Neck, Stomach & Gastrointestinal, Pancreatic, Breast, Liver and Other Cancer Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 195: Saudi Arabia Historic Review for Oncology Nutrition by Cancer Type - Head & Neck, Stomach & Gastrointestinal, Pancreatic, Breast, Liver and Other Cancer Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 196: Saudi Arabia 16-Year Perspective for Oncology Nutrition by Cancer Type - Percentage Breakdown of Value Sales for Head & Neck, Stomach & Gastrointestinal, Pancreatic, Breast, Liver and Other Cancer Types for the Years 2014, 2023 & 2030
    • TABLE 197: Saudi Arabia Recent Past, Current & Future Analysis for Oncology Nutrition by End-Use - Hospitals, Home Care and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 198: Saudi Arabia Historic Review for Oncology Nutrition by End-Use - Hospitals, Home Care and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 199: Saudi Arabia 16-Year Perspective for Oncology Nutrition by End-Use - Percentage Breakdown of Value Sales for Hospitals, Home Care and Other End-Uses for the Years 2014, 2023 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 200: UAE Recent Past, Current & Future Analysis for Oncology Nutrition by Cancer Type - Head & Neck, Stomach & Gastrointestinal, Pancreatic, Breast, Liver and Other Cancer Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 201: UAE Historic Review for Oncology Nutrition by Cancer Type - Head & Neck, Stomach & Gastrointestinal, Pancreatic, Breast, Liver and Other Cancer Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 202: UAE 16-Year Perspective for Oncology Nutrition by Cancer Type - Percentage Breakdown of Value Sales for Head & Neck, Stomach & Gastrointestinal, Pancreatic, Breast, Liver and Other Cancer Types for the Years 2014, 2023 & 2030
    • TABLE 203: UAE Recent Past, Current & Future Analysis for Oncology Nutrition by End-Use - Hospitals, Home Care and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 204: UAE Historic Review for Oncology Nutrition by End-Use - Hospitals, Home Care and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 205: UAE 16-Year Perspective for Oncology Nutrition by End-Use - Percentage Breakdown of Value Sales for Hospitals, Home Care and Other End-Uses for the Years 2014, 2023 & 2030
  • REST OF MIDDLE EAST
    • TABLE 206: Rest of Middle East Recent Past, Current & Future Analysis for Oncology Nutrition by Cancer Type - Head & Neck, Stomach & Gastrointestinal, Pancreatic, Breast, Liver and Other Cancer Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 207: Rest of Middle East Historic Review for Oncology Nutrition by Cancer Type - Head & Neck, Stomach & Gastrointestinal, Pancreatic, Breast, Liver and Other Cancer Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 208: Rest of Middle East 16-Year Perspective for Oncology Nutrition by Cancer Type - Percentage Breakdown of Value Sales for Head & Neck, Stomach & Gastrointestinal, Pancreatic, Breast, Liver and Other Cancer Types for the Years 2014, 2023 & 2030
    • TABLE 209: Rest of Middle East Recent Past, Current & Future Analysis for Oncology Nutrition by End-Use - Hospitals, Home Care and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 210: Rest of Middle East Historic Review for Oncology Nutrition by End-Use - Hospitals, Home Care and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 211: Rest of Middle East 16-Year Perspective for Oncology Nutrition by End-Use - Percentage Breakdown of Value Sales for Hospitals, Home Care and Other End-Uses for the Years 2014, 2023 & 2030
  • AFRICA
    • Oncology Nutrition Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2023 (E)
    • TABLE 212: Africa Recent Past, Current & Future Analysis for Oncology Nutrition by Cancer Type - Head & Neck, Stomach & Gastrointestinal, Pancreatic, Breast, Liver and Other Cancer Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 213: Africa Historic Review for Oncology Nutrition by Cancer Type - Head & Neck, Stomach & Gastrointestinal, Pancreatic, Breast, Liver and Other Cancer Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 214: Africa 16-Year Perspective for Oncology Nutrition by Cancer Type - Percentage Breakdown of Value Sales for Head & Neck, Stomach & Gastrointestinal, Pancreatic, Breast, Liver and Other Cancer Types for the Years 2014, 2023 & 2030
    • TABLE 215: Africa Recent Past, Current & Future Analysis for Oncology Nutrition by End-Use - Hospitals, Home Care and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 216: Africa Historic Review for Oncology Nutrition by End-Use - Hospitals, Home Care and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 217: Africa 16-Year Perspective for Oncology Nutrition by End-Use - Percentage Breakdown of Value Sales for Hospitals, Home Care and Other End-Uses for the Years 2014, 2023 & 2030

IV. COMPETITION

Show more
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Contact Us +1-866-353-3335
Hi, how can we help?
Contact us!